UNSPSC 51283721: Cefotiam hexetil hydrochloride

This classification denotes a cephalosporin antibiotic C27H37N9O7S3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3N1X7E8CLE, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, hydrochloride (1:2), (6r,7r)-, but more generally known as cefotiam hexetil hydrochloride, which bears US NIH Compound Identifier 175647.

UNSPSC 51283721 Cefotiam hexetil hydrochloride is a Commodity code that nominally describes a specific injectable antibiotic, yet recent state and local solicitations tagged under this code show minimal alignment with pharmaceutical manufacturing or direct cefotiam procurement. Instead, the tagged opportunities span emergency medical supplies, naloxone distribution, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical contracting — none of which center on cefotiam hexetil hydrochloride as an active ingredient or procurement line item. The mismatch between the code's narrow pharmaceutical-chemical scope and the breadth of health-system and emergency-response purchasing tagged to it suggests either miscoding in source systems or use of this code as a catch-all placeholder for pharmaceutical and health-supply categories. State and local buyers posting under this code include county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities in Minnesota and Oregon). The issuing-body mix reflects both standalone procurement by individual jurisdictions and centralized purchasing vehicles that aggregate demand across multiple states and local entities.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with opportunities posted between March and June 2026. The City of Tampa issued an IFB (26P00145) for medical and first aid supplies including respiratory equipment, cardiac monitoring devices, and consumables for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a response deadline of March 13, 2026; this procurement was designated as a sheltered market set-aside for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida released IFB60459723LAS seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Texas HHS Commission posted RFI HHS0017013 (due April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription program capabilities. The Minnesota Department of Administration issued an RFP through MMCAP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across authorized wholesalers, with a two-year term effective July 1, 2026. The code shows little relevant recent activity directly tied to cefotiam hexetil hydrochloride procurement.